Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 8 peer-reviewed journal articles Updated
Neuro-Ophthalmology

What Is the Spontaneous Visual Recovery Rate for LHON?

At a Glance

Spontaneous visual recovery in LHON is possible but varies widely. Younger onset and the m.14484T>C mutation are linked with better chances, while adult recovery is often limited. Most improvement occurs within the first two years, and a complete return to normal vision is uncommon.

The short answer is that spontaneous visual recovery—meaning your vision improves on its own without treatment—does happen in Leber Hereditary Optic Neuropathy (LHON), but it is not the most common outcome, especially for adults.

However, there is no single “recovery rate” that applies to everyone. Medical studies report widely different percentages because a patient’s chances depend heavily on their genetic mutation, age when symptoms began, and disease duration. Furthermore, different studies use different definitions of “recovery.” A complete return to normal, pre-illness vision is uncommon, though substantial recovery is possible [1].

What “Recovery” Actually Looks Like

When researchers and doctors talk about visual recovery in LHON, they usually mean a measurable improvement from the absolute worst point of your vision (the nadir) [1].

Recovery often means gaining back a few lines of readability on an eye chart or noticing that the central blind spot (scotoma) has shrunk or developed small areas of clearing (fenestrations) [2]. This can allow patients to use their vision more effectively to navigate or read with magnification, even if they still have severe visual impairment or meet their country’s criteria for legal blindness. Because changes in the visual field and changes in visual acuity (sharpness) do not always perfectly correspond, doctors monitor both to assess functional recovery [2].

How Mutation and Age Affect Recovery

LHON is caused by mutations in mitochondrial DNA. The three most common mutations have very different patterns of natural recovery:

  • The m.14484T>C mutation: Patients with this mutation generally have the best visual prognosis and the highest rates of spontaneous recovery, as well as less severe visual field loss [3][4][2].
  • The m.11778G>A mutation: This is the most common LHON mutation but generally carries a lower chance of spontaneous recovery. For adults with this mutation, a review of 15 studies found that only about 11% experienced meaningful recovery [5].
  • The m.3460G>A mutation: Like m.11778G>A, this variant tends to result in poorer average adult outcomes compared to m.14484T>C [3].

Age is also a critical predictor. Younger patients—especially those who develop symptoms in childhood or adolescence—have a significantly higher chance of recovery [6][7]. If symptoms start after age 50, the chances of spontaneous recovery are generally very low [7].

Making Sense of the Numbers

It can be confusing to read different statistics about LHON recovery. Percentages range from 11% to 70% in published literature because researchers measure different things. The table below illustrates how estimates vary based on the group studied and how recovery was defined:

Study Population Patient Age at Onset Definition of Recovery Reported Rate Citation
Meta-analysis of m.11778G>A Adults (≥15 years) “Meaningful recovery” (definitions varied) ~11% [5]
Korean Cohort (Mixed mutations) Childhood (≤13 years) Measurable visual acuity improvement 35% [6]
Korean Cohort (Mixed mutations) Later onset (>13 years) Measurable visual acuity improvement ~13% [6]
5-Year Cohort (m.11778 & m.14484) ≤19 years Reaching a visual acuity of roughly 20/200 by 5 years ~70% (modeled) [7]
5-Year Cohort (m.11778 & m.14484) 20–49 years Reaching a visual acuity of roughly 20/200 by 5 years ~14% (modeled) [7]

Note: These are population-level estimates from untreated or natural-history cohorts. Your individual prognosis requires specialist interpretation.

When Does Recovery Happen?

If spontaneous recovery is going to occur, it typically happens relatively early. In one study, 81% of patients who experienced recovery did so within the first two years after their symptoms started [1]. However, it is not impossible for improvements to happen later; researchers have documented some spontaneous visual acuity changes continuing years into the chronic phase [8].

What You Should Do Now

While the possibility of spontaneous recovery offers hope, waiting to see what happens is not a medical strategy. It is critical that you:

  1. Do not delay evaluation: See a neuro-ophthalmologist immediately to confirm your genetic diagnosis and discuss approved treatments (such as idebenone) or clinical trials. Do not make treatment decisions based solely on natural recovery rates.
  2. Protect your optic nerve: Clinicians strongly advise avoiding smoking and excessive alcohol consumption, as these can stress your remaining mitochondrial function.
  3. Start low-vision rehabilitation early: Do not wait for your final visual outcome to get help. Engaging with low-vision services (magnifiers, electronic aids, mobility training) can help you adapt, maintain your independence, and manage the emotional frustration of vision loss right now.

Common questions in this guide

What is the spontaneous visual recovery rate in LHON?
There is no single recovery rate for everyone. Published estimates vary widely because studies include different mutations, ages, and definitions of recovery; in adults with the m.11778G>A mutation, one review found meaningful recovery in about 11%. A complete return to normal vision is uncommon, although substantial improvement can occur.
Which LHON mutation gives the best chance of vision recovery?
Among the common LHON mutations, m.14484T>C is generally associated with the most favorable visual prognosis and the highest spontaneous recovery rates. m.11778G>A and m.3460G>A generally have poorer average adult outcomes.
Does age affect the chance of visual recovery in LHON?
Yes. People whose symptoms begin in childhood or adolescence are more likely to recover than adults, while symptom onset after age 50 is generally linked with a very low chance of spontaneous recovery.
How soon does spontaneous visual recovery usually occur in LHON?
When recovery occurs, it usually begins relatively early. In one study, 81% of people who recovered did so within two years of symptom onset, although later changes can still occur during the chronic phase.
Can LHON vision return completely to normal?
A complete return to pre-illness vision is uncommon. Recovery more often means a measurable gain from the worst point, such as improved visual acuity or a smaller central blind spot, while significant visual impairment may remain.
What should I do while waiting to see if my LHON vision improves?
Do not delay evaluation by a neuro-ophthalmologist or make treatment decisions based only on natural recovery statistics. Ask about options such as idebenone or clinical trials, avoid smoking and excessive alcohol, and start low-vision rehabilitation early if needed.

Related questions

What Is LHON Plus and Which Symptoms Can It Cause? How Does Idebenone Treat LHON? How Long Should I Take It? Who Is Eligible for LHON Gene Therapy Trials (Lumevoq)? Does LHON Cause Complete Blindness? Vision Loss Explained How Do LHON Mutations Differ in Prognosis and Recovery?
Show more
At What Age Do LHON Symptoms Usually Begin in Carriers? Can LHON Mothers Pass It On—and Will Children Have Symptoms? Can Fathers Pass LHON to Their Children? Inheritance Can You Still Drive with LHON? Vision and Licensing Rules How Soon Does LHON Affect the Second Eye? Typical Timeline Is Leber Hereditary Optic Neuropathy Vision Loss Painless? What Is the Bilateral Transfer Effect in LHON Gene Therapy? What Low-Vision Help Is Available for LHON Patients? What Triggers Sudden Vision Loss in LHON Carriers? What Vitamins and Supplements Are Recommended for LHON? Why Are Smoking and Alcohol Dangerous for LHON Patients? Why Doesn't Steroid Treatment Improve LHON Vision Loss? Why Is an MRI Used for Leber Hereditary Optic Neuropathy? Why Should LHON Patients Avoid BAK-Preserved Eye Drops?

Get notified when new evidence is published on Leber hereditary optic neuropathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (8)
  1. 1

    Clinical and Optic Disc Characteristics of Patients Showing Visual Recovery in Leber Hereditary Optic Neuropathy.

    Moon Y, Kim US, Han J, et al.

    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 2020; (40(1)):15-21 doi:10.1097/WNO.0000000000000830.

    PMID: 31609832
  2. 2

    Archetypal Visual Field Analysis of Patients With Chronic Leber Hereditary Optic Neuropathy in Relation to Visual Recovery.

    Coutinho CP, Zanchetta F, Carbonelli M, et al.

    Investigative ophthalmology & visual science 2026; (67(8)):8 doi:10.1167/iovs.67.8.8.

    PMID: 42390170
  3. 3

    Natural history of patients with Leber hereditary optic neuropathy-results from the REALITY study.

    Yu-Wai-Man P, Newman NJ, Carelli V, et al.

    Eye (London, England) 2022; (36(4)):818-826 doi:10.1038/s41433-021-01535-9.

    PMID: 33911213
  4. 4

    Variant and clinical landscape of Leber hereditary optic neuropathy based on 1516 families with mtDNA variants in a tertiary centre.

    Zheng Y, Wang Y, Jiang Y, et al.

    The British journal of ophthalmology 2024; (108(9)):1318-1327 doi:10.1136/bjo-2023-323557.

    PMID: 38346855
  5. 5

    Visual Outcomes in Leber Hereditary Optic Neuropathy Patients With the m.11778G>A (MTND4) Mitochondrial DNA Mutation.

    Newman NJ, Carelli V, Taiel M, Yu-Wai-Man P

    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 2020; (40(4)):547-557 doi:10.1097/WNO.0000000000001045.

    PMID: 32969847
  6. 6

    Genotypic and phenotypic characteristics of Korean children with childhood-onset Leber's hereditary optic neuropathy.

    Ahn YJ, Park Y, Shin SY, et al.

    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2020; (258(10)):2283-2290 doi:10.1007/s00417-020-04757-x.

    PMID: 32506279
  7. 7

    Five-year post-onset visual acuity trajectories in Japanese Leber hereditary optic neuropathy: a longitudinal analysis by age, sex, and mtDNA mutation.

    Takai Y, Yamagami A, Iwasa M, et al.

    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 2026; (61(4)):901-907 doi:10.1016/j.jcjo.2026.02.011.

    PMID: 41833325
  8. 8

    Visual acuity changes in idebenone treatment‑naïve patients with Leber hereditary optic neuropathy: insights from the CRS-2 study.

    Krawczynski MR, van Everdingen J, Leroy BP, et al.

    Journal of neurology 2026; (273(11)).

    PMID: 42955336

This information about LHON visual recovery is for educational purposes only and does not constitute medical advice. A neuro-ophthalmologist should interpret your prognosis and discuss treatment or rehabilitation options.